| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01250518 |
| P698 | PubMed publication ID | 1281646 |
| P50 | author | Peter A. Lewitt | Q67215217 |
| Nunzio Pomara | Q40337390 | ||
| P2093 | author name string | M. Stanley | |
| R. Singh | |||
| M. Galloway | |||
| D. Deptula | |||
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| The cholinergic hypothesis of geriatric memory dysfunction | Q28277644 | ||
| Measuring cholinergic sensitivity: II. Arecoline effects on metabolic activity in pontine regions of rat brain | Q48944715 | ||
| The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia | Q49028545 | ||
| Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. | Q50869517 | ||
| Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism | Q51160311 | ||
| Oxotremorine and central monoamine neurons | Q51200876 | ||
| Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans. | Q51219060 | ||
| Effects of atropine on learning and memory functions in dementia. | Q52107777 | ||
| Memory and cognitive function in man: Does the cholinergic system have a specific role? | Q52239045 | ||
| Dopamine in Alzheimer's disease and senile dementia | Q53178127 | ||
| Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. | Q53192718 | ||
| Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. | Q53196670 | ||
| Presynaptic cholinergic dysfunction in patients with dementia. | Q53198289 | ||
| Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. | Q54385550 | ||
| Cerebrospinal fluid flow and iodide 131 transport in the spinal subarachnoid space. | Q54461036 | ||
| The Global Deterioration Scale for assessment of primary degenerative dementia | Q57279034 | ||
| Denervation, supersensitivity and muscarinic receptors in the cat iris | Q59417195 | ||
| Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates | Q69727975 | ||
| Cholinergic drug effects and brain muscarinic receptor binding in aged rats | Q70720493 | ||
| Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion | Q71539716 | ||
| Muscarinic receptor compensation in hippocampus of Alzheimer patients | Q72553350 | ||
| Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia | Q33619754 | ||
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 | ||
| CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders | Q37057057 | ||
| Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study | Q38489258 | ||
| Choline Administration: Activation of Tyrosine Hydroxylase in Dopaminergic Neurons of Rat Brain | Q39119441 | ||
| Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine | Q39173004 | ||
| Neocortical cholinergic neurons in elderly people | Q39428914 | ||
| Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain | Q39743126 | ||
| Pre- and postsynaptic neurochemical alterations in Alzheimer's disease | Q40196582 | ||
| Drug-induced changes of dopamine turnover in striatum and limbic system of the rat | Q40321966 | ||
| Multiple-dose arecoline infusions in Alzheimer's disease | Q41781970 | ||
| Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. | Q41958103 | ||
| Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain | Q41962167 | ||
| Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease | Q42453090 | ||
| Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease | Q44466201 | ||
| Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders | Q45030829 | ||
| Neurotransmitters and CNS disease. Dementia | Q45303741 | ||
| Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry | Q45308892 | ||
| VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type | Q48108260 | ||
| Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex | Q48171808 | ||
| Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains | Q48244288 | ||
| Chemical pathology of this organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains | Q48269217 | ||
| Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type | Q48284780 | ||
| Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type | Q48298226 | ||
| Necropsy evidence of central cholinergic deficits in senile dementia | Q48319379 | ||
| Action of arecoline on the levels of acetylcholine, norepinephrine and dopamine in the mouse central nervous system | Q48335319 | ||
| Selective loss of central cholinergic neurons in Alzheimer's disease | Q48342983 | ||
| Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia | Q48391811 | ||
| Correlations between aminergic metabolites simultaneously obtained from human CSF and brain | Q48446132 | ||
| Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging | Q48448569 | ||
| Brain muscarinic receptors in senile dementia | Q48479457 | ||
| Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation | Q48486635 | ||
| Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system | Q48529542 | ||
| Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium | Q48562532 | ||
| Changes in neostriatal da metabolism after carbachol or atropine microinjections into the substantia nigra | Q48570610 | ||
| Studies Related to the Cholinergic Influence on the Accumulation and Disappearance of Monoamines in Rat Brain | Q48614130 | ||
| Chronic scopolamine treatment and brain cholinergic function | Q48670483 | ||
| Studies on neurotransmitter binding in senile dementia. Comparison of Alzheimer's and mixed vascular-Alzheimer's dementias | Q48695072 | ||
| Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease). | Q48696259 | ||
| Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus | Q48709196 | ||
| A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease | Q48712776 | ||
| Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry | Q48826879 | ||
| Cortical muscarinic receptor subtypes and Alzheimer's disease | Q48860487 | ||
| Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications? | Q48882108 | ||
| Effects of oxotremorine on local glucose utilization in the rat cerebral cortex. | Q48914665 | ||
| Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia | Q48922425 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 53-65 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Journal of neural transmission. General section | Q27709566 |
| P1476 | title | Increased CSF HVA response to arecoline challenge in Alzheimer's disease | |
| P478 | volume | 90 |
| Q93332915 | Pathological Increases in Neuronal Hyperactivity in Selective Cholinergic and Noradrenergic Pathways May Limit the Efficacy of Amyloid-β-Based Interventions in Mild Cognitive Impairment and Alzheimer's Disease | cites work | P2860 |
Search more.